Ignite Creation Date:
2025-12-26 @ 10:36 AM
Ignite Modification Date:
2026-03-12 @ 6:33 PM
Study NCT ID:
NCT06582628
Status:
RECRUITING
Last Update Posted:
2024-12-02
First Post:
2024-08-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC)
Sponsor:
Fundacion Oncosur
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Prostate Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Prostatic Diseases | View |
| None | Prostatic Cancer | View |
| None | metastatic castration resistant prostate cancer (mCRPC) | View |
| None | prostate adenocarcinoma | View |
| None | metastatic hormone-sensitive prostate cancer | View |
| None | Poly (ADP-ribose) Polymerases (PARP) | View |
| None | Prostate Specific Antigen | View |
| None | Abiraterone | View |